For context, Humana's shares have experienced a total return decline of 35.19% over the past ... insights into our analysis of Humana stock in this financial health report.

For context, Humana's shares have experienced a total return decline of 35.19% over the past year ... Unlock comprehensive insights into our analysis of Humana stock in this financial health report.

Shares of UnitedHealth Group sank sharply on Tuesday as the health insurance giant replaced its CEO and suspended its 2025 outlook.

Peers CVS (CVS), Centene (CNC), Elevance (ELV), and Humana (HUM) also dip ... The significant stock decline may present a buying opportunity for long-term investors who believe in the company's ...

Humana Inc. (HUM ... dip on a YTD basis outshine the stock’s low double-digit losses over the same time frame. HUM’s underperformance can be linked to decline in investment income, fall ...

With Tuesday’s losses, the stock is now down more than 38% for the ... but those shares have managed to rebound. Rivals Humana and Elevance Care have said they have not seen unusually high ...

JPMorgan Chase & Co. dropped their price target on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 18th. Robert W. Baird ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Humana Inc. (NYSE:HUM – Get Free Report)’s share price gapped down before the market opened on Tuesday after Truist Financial lowered their price target on the stock from $325.00 to $305.00.

Shares of Humana Inc. HUM advanced 1.33% to $252.86 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 3.26% to 5,844.19 ...